Parallelizing Drug Discovery: HPC Pipelines for Alzheimer’s Molecular Docking and Simulation
Paul Ruiz Alliata 1, Diana Rubaga 1, Daniel Kumlin 1, Alberto Puliga 1 1 Computer Science and Artificial Intelligence Department, IE University, Madrid, Spain · 2025
Read Parallelizing Drug Discovery: HPC Pipelines for Alzheimer’s Molecular Docking and Simulation by Paul Ruiz Alliata 1, Diana Rubaga 1, Daniel Kumlin 1, Alberto Puliga 1 1 Computer Science and Artificial Intelligence Department, IE University, Madrid, Spain (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2509-00937.txt.
Description
Paul Ruiz Alliata, with three co-authors, explores computing pipelines for Alzheimer's drug discovery. High-performance computing can reshape discovery through fast simulations. The work focuses on virtual screening, docking, and dynamics runs. Targets include amyloid-beta and tau proteins. Both proteins are tied to the disease in the record.
The team implements a parallel workflow using GROMACS. It uses hybrid MPI-OpenMP strategies to split the work. Scaling is benchmarked across minimisation, equilibration, and production stages. A docking prototype shows large runtime gains from process-based parallelism. Python's multiprocessing library drives that speedup in their tests. Case studies cover prolinamide derivatives and baicalein. Limits remain in data management, costs, and scaling. Still, the potential to speed up drug discovery is clear.
Catalog record
| CREATOR | Paul Ruiz Alliata 1, Diana Rubaga 1, Daniel Kumlin 1, Alberto Puliga 1 1 Computer Science and Artificial Intelligence Department, IE University, Madrid, Spain |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2509-00937